BridgeBio Pharma BBIO
NASDAQ BBIO
$79.54 +0.87 (+1.11%)
At close: Nov 11, 2026 · 4:00 PM EST

BridgeBio Pharma (BBIO) Total Non-Current Liabilities (2018 - 2026)

Updated

BridgeBio Pharma (BBIO) recorded Total Non-Current Liabilities of $3.82 billion in Q3 2026, up 30.9% from $2.92 billion a year earlier and up 2.7% from the prior quarter.

Analysis

BridgeBio Pharma (BBIO) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends

At the end of FY2025, BridgeBio Pharma reported Total Non-Current Liabilities of $3.02 billion, up 27.2% from FY2024.

  • Annual Total Non-Current Liabilities has increased for three straight years, with a five-year compound annual growth rate of 38.7% (FY2020 to FY2025).
  • Across earlier years, Total Non-Current Liabilities came in at $2.38 billion in FY2024 (+26.2%), $1.88 billion in FY2023 (+2.4%), $1.84 billion in FY2022 (-1.0%) and $1.86 billion in FY2021 (+216.0%).
  • The Q3 2026 figure is the highest quarterly Total Non-Current Liabilities in data going back to Q4 2018.
  • On a year-over-year basis, Total Non-Current Liabilities has increased for 13 consecutive quarters, with growth averaging 37.5% over the last eight quarters.
  • Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 216.0% in Q4 2021, against a decline of 1.0% in Q4 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $3.72 billion (Q2 2026), $3.64 billion (Q1 2026) and $3.02 billion (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 60.81 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 102.65 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 117.60 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 79.95 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -36.84 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 76.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 36.05 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 96.04 Bn
10 BridgeBio Pharma 15.42 Bn 11.64 Bn 332.72 Mn 3.82 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 3.82 Bn
Jun 30, 2026 3.72 Bn
Mar 31, 2026 3.64 Bn
Dec 31, 2025 3.02 Bn
Sep 30, 2025 2.92 Bn
Jun 30, 2025 2.86 Bn
Mar 31, 2025 2.52 Bn
Dec 31, 2024 2.38 Bn
Sep 30, 2024 1.88 Bn
Jun 30, 2024 1.88 Bn
Mar 31, 2024 1.89 Bn
Dec 31, 2023 1.88 Bn
Sep 30, 2023 1.84 Bn
Jun 30, 2023 1.84 Bn
Mar 31, 2023 1.82 Bn
Dec 31, 2022 1.84 Bn
Sep 30, 2022 1.83 Bn
Jun 30, 2022 1.85 Bn
Mar 31, 2022 1.83 Bn
Dec 31, 2021 1.86 Bn
API Access

BridgeBio Pharma Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=BBIO&period=max&api_key=YOUR_API_KEY